Product Information

CLONAZEPAM 1 MG ODT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5435 per EA under NDC 62332036706. Its NADAC has been published 365 times since Nov 20, 2019.

FDA first approved this application on Jun 28, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 1 MG ODT

CLONAZEPAM
$0.5435per EA
DEA Schedule CIV

Strength

1 mg/1

NDC

62332036706

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA211033

FDA Approved

6/28/2019

TE Code

AB

On Market Since

7/1/2019

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 1 MG ODT has been published 365 times since Nov 20, 2019, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5435 per EA
All-time high$0.8553 (Mar 16, 2022)
All-time low$0.4241 (Mar 22, 2023)
52-week high$0.5921
52-week low$0.5150
Median price$0.6388
Average price$0.6486
Largest weekly change+48.7% (Jun 19, 2024)
Weeks tracked365
Tracking sinceNov 20, 2019

Price History

1W

0.0%

1M

-4.1%

3M

-5.9%

6M

+2.0%

1Y

+2.8%

3Y

+14.2%

5Y

-31.0%

All

-11.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLONAZEPAM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 1 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG ODT, manufactured by Alembic Pharmaceuticals Inc., is $0.5435 per EA (NDC 62332036706), effective Nov 11, 2026.

How has the price of CLONAZEPAM 1 MG ODT changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 1 MG ODT has declined 11.5%. It has been tracked across 365 weekly CMS publications since Nov 20, 2019.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG ODT?

Since Nov 20, 2019, the NADAC for CLONAZEPAM 1 MG ODT has ranged from a low of $0.4241 (Mar 22, 2023) to a high of $0.8553 (Mar 16, 2022), with a median of $0.6388 per EA.

Are there cheaper alternatives to CLONAZEPAM 1 MG ODT?

No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 1 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLONAZEPAM 1 MG ODT?

CLONAZEPAM 1 MG ODT (NDC 62332036706) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.